John Valliant

Founder presso FUSN PHAR

Patrimonio netto: 7 M $ in data 31/03/2024

54 anni

Health Technology

Consumer Services

Profilo

John Valliant is the founder of Fusion Pharmaceuticals, Inc. (2014) and Centre For Probe Development & Commercialization (2008), where he holds the titles of Chief Executive Officer & Director and Independent Director & Principal Investigator, respectively.
He is currently a Professor at McMaster University, a position he has held since 1999.
Dr. Valliant earned a doctorate degree from McMaster University.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
FUSION PHARMACEUTICALS INC 0.38%	04/01/2024	318 147 ( 0.38% )	7 M $	31/03/2024

Posizioni attive di John Valliant

Società	Posizione	Inizio
FUSN PHAR	Founder	01/12/2014
Centre For Probe Development & Commercialization Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.	Founder	01/03/2008
McMaster University	Corporate Officer/Principal	01/01/1999

Tutte le posizioni attive di John Valliant

Formazione di John Valliant

McMaster University

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di John Valliant

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
FUSN PHAR	Health Technology

Aziende private	1
Centre For Probe Development & Commercialization Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.	Health Technology